EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation

Duaa M Alsholi iD, Ghazi Suleiman Yacoub, Ata Ur Rehman, Hidayat Ullah, Asif Iqbal Khan iD, Ting Deng, Nimra Zafar Siddiqui iD, Yamina Alioui, Nabeel Ahmed Farooqui iD, Maroua Elkharti, Yanxia Li, Liang Wang iD und 1 weitere

Pathogens · 11.11.2023 · 12 (11) · 1340

DOI: 10.3390/pathogens12111340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 11.11.2023. Verfasst von Duaa M Alsholi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Scholarship Council grant number, the National Nature Science Foundation of China, Dalian Science and Technology Innovation Fund Application Foundation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lactobacillus rhamnosus (LBS) is a well-documented probiotic strain in oncology and has a pivotal role in clinical applications. Here, we have investigated the protective effect of Lactobacillus rhamnosus on intestinal mucositis induced by cisplatin (CP) and explored the underlying mechanisms targeting inflammatory proteins, as well as the histological changes in the intestinal tissue of mice, in addition, the bacterial strains that may be related to the health-enhancing properties. BALB/c mice were pre-treated with or without LBS via oral gavage, followed by mucositis induction with cisplatin. Our results revealed that the LBS-treated groups significantly attenuated proinflammatory cytokine levels (IL-1β, IL-6, and TNF-α) compared to the CP group. Furthermore, LBS mitigated the damaged tight junction integrity caused by CP via up-regulating the levels of claudin, occludin, ZO-1, and mucin-2 protein (MUC-2). Finally, the 16S rRNA fecal microbiome genomic analysis showed that LBS administration enhanced the growth of beneficial bacteria, i.e., Firmicutes and Lachnospiraceae, while the relative abundance of the opportunistic bacteria Bacteroides and Proteobacteria decreased. Collectively, LBS was found to beneficially modulate microbial composition structure and functions and enrich the ecological diversity in the gut.

Schlagwörter

Stichwörter der Autor:innen

16S rRNA fecal microbiomeLactobacillus rhamnosuscisplatinintestinal mucositisprobioticproinflammatory cytokines

Autor:innen und Institutionen

  • Department of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
  • Department of Dermatology, The First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Lu, Dalian 116011, China.
  • Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
  • Stem Cell Clinical Research Center, National Joint Engineering Laboratory, Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.

ORCID-Profile: Duaa M Alsholi, Asif Iqbal Khan, Nimra Zafar Siddiqui, Nabeel Ahmed Farooqui, Liang Wang, Yi Xin

Förderung

  • Chinese Scholarship Council grant number
  • the National Nature Science Foundation of China
  • Dalian Science and Technology Innovation Fund Application Foundation Project
  • Liaoning Natural Science Foundation Program
  • Dalian outstanding young scientific and technological talents
  • Chinese Scholarship Council

Zitieren

APA

Alsholi, D. M., Yacoub, G. S., Rehman, A. U., Ullah, H., Khan, A. I., Deng, T., Siddiqui, N. Z., Alioui, Y., Farooqui, N. A., Elkharti, M., Li, Y., Wang, L., & Xin, Y. (2023). Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation. Pathogens, 12(11), 1340. https://doi.org/10.3390/pathogens12111340

Vancouver

Alsholi DM, Yacoub GS, Rehman AU, Ullah H, Khan AI, Deng T, et al. Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation. Pathogens. 2023;12(11):1340. doi:10.3390/pathogens12111340

BibTeX
@article{Alsholi2023,
  author = {Alsholi, Duaa M and Yacoub, Ghazi Suleiman and Rehman, Ata Ur and Ullah, Hidayat and Khan, Asif Iqbal and Deng, Ting and Siddiqui, Nimra Zafar and Alioui, Yamina and Farooqui, Nabeel Ahmed and Elkharti, Maroua and Li, Yanxia and Wang, Liang and Xin, Yi},
  title = {Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation},
  journal = {Pathogens},
  year = {2023},
  volume = {12},
  number = {11},
  pages = {1340},
  doi = {10.3390/pathogens12111340}
}
Kostenlos starten →